Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol Consumption
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 21, 2024 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 in eClinicalMedicine.
Mohsan Subhani, M.B.B.S., from the University of Nottingham in the United Kingdom, and colleagues conducted a systematic literature review to evaluate the existing literature on the association between GLP-1 RAs and alcohol consumption.
The researchers identified six studies (88,190 participants; 43.9 percent receiving GLP-1 RAs). However, only 286 participated in randomized controlled trials (RCTs), which did not show a reduction in alcohol consumption over 30 days after 24 weeks of treatment with exenatide versus placebo. In a subgroup analysis, there was a positive effect in people with obesity, with significant reductions in brain reward center cue reactivity on functional magnetic resonance imaging. Among RCT participants, those taking dulaglutide were more likely to reduce alcohol intake compared with placebo (relative effect size, 0.71). Fewer alcohol-related health care events and a significant reduction in alcohol use were seen in observational studies comparing GLP-1 RA treatment to dipeptidyl peptidase 4 use, no treatment, and/or alcohol intake at baseline.
"There is little high-quality evidence demonstrating the effect of GLP-1 RAs on alcohol use," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Young Women Show Greater Increase in Past-Month Binge Drinking Than Men
THURSDAY, April 24, 2025 -- The sex-based differences in past-month binge drinking among young adults reversed in 2021-2023 versus 2017-2019, with higher rates emerging among...
Moderate, Heavy Alcohol Consumption Linked to Signs of Injury in the Brain
FRIDAY, April 11, 2025 -- Moderate, heavy, and former heavy alcohol consumption are associated with hyaline arteriolosclerosis and neurofibrillary tangles, according to a study...
1992 to 2021 Saw Decrease in Burden of Alcohol-Related Cirrhosis in Women
MONDAY, April 7, 2025 -- The burden of alcohol-related cirrhosis (AC) among women has decreased but is disproportionately high in lower Sociodemographic Index (SDI) regions...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.